puan noraimy binti abdullah

jururawat

jab pengurusan kejururawatan, hukm

 noraimy.abdullah@ppukm.ukm.edu.my



   Biografi/ Biography :

  • JURURAWAT

  • t. s. lim, w. nyunt, k. then, s. cheong, k. then, g. ooi, v. govindasamy, m. mohd idris, s. azura, n. abdullah, m. muhd zakaria, a. h. chang, a. ithnin , s. s. abdul wahid.  (2023).  locally manufactured autologous cd19 chimeric antigen receptor-t (car-t) cells for phase ii prospective clinical trial for relapsed/refractory b-acute lymphoblastic leukaemia in malaysia.  - cytotherapy.  S225-S226. 

     

    s fadilah abdul wahid1, wint wint thu nyunt2, timothy lim2, mohd razif mohd idris1, muhd zanapiah muhd zakaria1,3, alex chang h s4, wan fariza wan jamaludin1, loh c-khai5, hamidah alias5, suria abd aziz6, azlin ithnin7, seery zaliza azura1, noraimy abdu.  (2022).  autologous cd19 chimeric antigen receptor-t therapy for relapsed/ refractory b-acute lymphoblastic leukaemia patients- a phase ii clinical trial in malaysia.  - 19th malaysian society haematology scientific meeting 2022.  50. 

     

    wint wint thu nyunt, seery zaliza azura zaider, noraimy abdullah, wan fariza wan jamaludin, muhd zanapiah zakaria, s fadilah s abdul wahid.  (2020).  survival outcomes of patients after haematopoietic cell transplantation for haematological disorders: a 20 year experience in malaysia, ukm medical centre.  - 17th malaysian society of haematology scientific meeting.  65. 

     

    wan fariza binti wan jamaludin, fadilah binti abdul wahid, mohd razif bin mohd idris, nor azimah binti ismail, seery zaliza azura binti zaider, noraimy abdullah.  (2020).  guidelines: cytokine release syndrome.  - 1-5. 

     

    wan fariza wan jamaludin, farina mohamad yusoff, nor azimah ismail, mohd razif mohd idris, sivakumar palaniappan, christopher ng kee kiat, noraimy abdullah, seery zaliza azura zaider, s fadilah abdul wahid.  (2019).  autologous mononuclear cells from different sources are seen to improve wound healing in patients with hematological malignancies.  - 16th msh annual scientific meeting.  67. 

     

    t. s. lim, w. nyunt, k. then, s. cheong, k. then, g. ooi, v. govindasamy, m. mohd idris, s. azura, n. abdullah, m. muhd zakaria, a. h. chang, a. ithnin , s. s. abdul wahid.  (2023).  locally manufactured autologous cd19 chimeric antigen receptor-t (car-t) cells for phase ii prospective clinical trial for relapsed/refractory b-acute lymphoblastic leukaemia in malaysia.  - cytotherapy.  S225-S226. 

     

    wan fariza wan jamaludin, farina mohamad yusoff, nor azimah ismail, mohd razif mohd idris, sivakumar palaniappan, christopher ng kee kiat, noraimy abdullah, seery zaliza azura zaider and s. fadilah s. abdul wahid.  (2018).  autologous mononuclear cells from different sources are seen to improve wound healing in patients with haematological malignancies.  - the malaysian journal of pathology.  61-67. 

     

    wint wint thu nyunt, rahayu draman, aida widure mohd mustapha, noralisa abdul karim, mohd razif mohd idris, noraimy abdullah, tang yee loong, wan fariza wan jamaludin, noraidah masir & s fadilah s abdul wahid.  (2018).  multi-disciplinary approach for managing plasmacytoma: a case report.  - sains malaysiana.  2113-2118. 

     

    t. s. lim, w. nyunt, k. then, s. cheong, k. then, g. ooi, v. govindasamy, m. mohd idris, s. azura, n. abdullah, m. muhd zakaria, a. h. chang, a. ithnin , s. s. abdul wahid.  (2023).  locally manufactured autologous cd19 chimeric antigen receptor-t (car-t) cells for phase ii prospective clinical trial for relapsed/refractory b-acute lymphoblastic leukaemia in malaysia.  - cytotherapy.  S225-S226. 

     

    wint wint thu nyunt, rahayu draman, aida widure mohd mustapha, noralisa abdul karim, mohd razif mohd idris, noraimy abdullah, tang yee loong, wan fariza wan jamaludin, noraidah masir & s fadilah s abdul wahid.  (2018).  multi-disciplinary approach for managing plasmacytoma: a case report.  - sains malaysiana.  2113-2118. 

     

    wan fariza wan jamaludin, farina mohamad yusoff, nor azimah ismail, mohd razif mohd idris, sivakumar palaniappan, christopher ng kee kiat, noraimy abdullah, seery zaliza azura zaider and s. fadilah s. abdul wahid.  (2018).  autologous mononuclear cells from different sources are seen to improve wound healing in patients with haematological malignancies.  - the malaysian journal of pathology.  61-67. 

     

    s fadilah abdul wahid1, wint wint thu nyunt2, timothy lim2, mohd razif mohd idris1, muhd zanapiah muhd zakaria1,3, alex chang h s4, wan fariza wan jamaludin1, loh c-khai5, hamidah alias5, suria abd aziz6, azlin ithnin7, seery zaliza azura1, noraimy abdu.  (2022).  autologous cd19 chimeric antigen receptor-t therapy for relapsed/ refractory b-acute lymphoblastic leukaemia patients- a phase ii clinical trial in malaysia.  - 19th malaysian society haematology scientific meeting 2022.  50. 

     

    wint wint thu nyunt, seery zaliza azura zaider, noraimy abdullah, wan fariza wan jamaludin, muhd zanapiah zakaria, s fadilah s abdul wahid.  (2020).  survival outcomes of patients after haematopoietic cell transplantation for haematological disorders: a 20 year experience in malaysia, ukm medical centre.  - 17th malaysian society of haematology scientific meeting.  65. 

     

    wan fariza binti wan jamaludin, fadilah binti abdul wahid, mohd razif bin mohd idris, nor azimah binti ismail, seery zaliza azura binti zaider, noraimy abdullah.  (2020).  guidelines: cytokine release syndrome.  - 1-5. 

     

    wan fariza wan jamaludin, farina mohamad yusoff, nor azimah ismail, mohd razif mohd idris, sivakumar palaniappan, christopher ng kee kiat, noraimy abdullah, seery zaliza azura zaider, s fadilah abdul wahid.  (2019).  autologous mononuclear cells from different sources are seen to improve wound healing in patients with hematological malignancies.  - 16th msh annual scientific meeting.  67. 

     

    wf wan jamaludin,ni pison, n saeed, a ibrahim, na abdullah1, sza zaider, s abdul razak, a zakaria, sy hashim, sk palaniappan, t mahaletchumy, s umar, s shuib, sf abdul wahid.  (2018).  relapsed refractory myeloma: local experience with carfilzomib.  - 15th msh annual scientific meeting.